Schwannoma MRI

Schwannoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Schwannoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Biopsy
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Schwannoma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Schwannoma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Schwannoma MRI
CDC on Schwannoma MRI
Schwannoma MRI in the news
Blogs on Schwannoma MRI
Directions to Hospitals Treating Schwannoma
Risk calculators and risk factors for Schwannoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: ; Maneesha Nandimandalam, M.B.B.S.[2]

MRI

Schwannomas have fairly predictable signal characteristics 7:

• T1: isointense or hypointense
• T1 C+ (Gd): intense enhancement
• T2: heterogeneously hyperintense (Antoni A: relatively low, Antoni B: high)
  • cystic degenerative areas may be present, especially in larger tumors
• T2*: larger tumors often have areas of hemosiderin

A number of signs can also be useful:

• split-fat sign: thin peripheral rim of fat best seen on planes along long axis of the lesion in non-fat-suppressed sequences
• target sign
  • peripheral high T2 signal
  • central low signal
  • rarely seen intracranially 7
• fascicular sign: multiple small ring-like structures